VarmX has received IND approval for its Phase 3 trial of VMX‑C001, a recombinant factor X variant designed to neutralize FXa‑inhibiting anticoagulants during emergency surgery. Backed by robust Phase 1 data and boosted by a €15 million EIC investment, this step positions…
𝗛𝗼𝘄 𝗱𝗼 𝘄𝗲 𝘁𝘂𝗿𝗻 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗸𝗻𝗼𝘄𝗹𝗲𝗱𝗴𝗲 𝗶𝗻𝘁𝗼 𝗿𝗲𝗮𝗹 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀, 𝗳𝗮𝘀𝘁𝗲𝗿, 𝘀𝗺𝗮𝗿𝘁𝗲𝗿, 𝗮𝗻𝗱 𝘁𝗼𝗴𝗲𝘁𝗵𝗲𝗿? That’s the question Key Region Leiden is working to answer. Launched on July 7 at Leiden Bio Science Park, this new regional partnership brings together seven municipalities,…
On July 3, 2025, Progress – Experts in Life Sciences announced its acquisition of Methnani & Associates, a consultancy specialised in pharmaceutical microbiology and sterility assurance. The move strengthens Progress’s position in the field of quality and regulatory services for…
On June 1, 2025, the Leiden University Medical Center (LUMC) officially opened its Post-COVID Expertise Centre, strengthening its role in national efforts to understand and treat long-term effects of COVID-19. The centre is part of the Post-COVID Network Netherlands and…
A decade of change at Leiden Bio Science Park has been captured in a newly released publication: Campus in Bloom – Stories of Growth, Connection and Innovation. This visually rich book documents the park’s evolution from a fragmented collection of…
Peter Lindenburg winnaar VUURVLIEGEN tijdens Dutch Bio Science Week Den Haag, 4 juli 2025 – Bijna 130 leerlingen van vier basisscholen uit de Leidse regio hebben onderzoeker Peter Lindenburg van Hogeschool Leiden uitgeroepen tot winnaar van de wetenschapsbattle VUURVLIEGEN. Na…
Dutch Bio Science Week 2025 has brought an extraordinary buzz to Leiden, transforming the city and the Bio Science Park into a hub of discovery, connection, and inspiration. Over the past days, professionals, researchers, students, and curious visitors have come…
The Court of Audit visited LBSP to explore how science and entrepreneurship create public value, with stops at TNO, Peregrion, NTrans, and VarmX sparking discussion on biotech innovation.
Leiden University is studying emotions at Lowlands Festival through two projects: a haunted house that measures how people cope with fear, and a silent performance exploring nonverbal communication.
LUMC and Stichting DON have launched Cure One, a new research center focused on accelerating curative therapies for type 1 diabetes through stem cell technology and immune-based treatments.
Thank you to everyone who joined us last Thursday at Grand Café de Stal. The room was full of energy, curiosity, and conversation as we explored the next wave of biotech innovation together. A special thanks to our speakers: 🟠…
Four Leiden University researchers have each received €2.5 million ERC Advanced Grants to pursue innovative projects in social inequality, medical placebo effects, type 1 diabetes treatment, and community-based climate adaptation, aiming to make significant scientific and societal contributions.